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Abstract The endogenous cannabinoid arachidonoylethanol-
amide was previously reported to have no effects on the
phospholipase D activity in Chinese hamster ovary cells
expressing the human brain-specific cannabinoid receptor, while
in mouse peritoneal cells, v9-tetrahydrocannabinol stimulated
this enzyme. In this work, arachidonoylethanolamide (0.1^1 WM)
was found to stimulate the phospholipase D-mediated phospho-
lipid hydrolysis in rat adrenal pheochromocytoma PC12 cells,
but not in mouse NIH 3T3 fibroblasts. The phospholipase
D-activating effects of arachidonoylethanolamide were compar-
able to those elicited by phorbol ester and nerve growth factor,
while arachidonic acid (1 WM) had no effects. The results show
that, depending on the cell type, arachidonoylethanolamide can
be an activator of the phospholipase D system.
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1. Introduction
The arachidonic acid derivative arachidonoylethanolamide
(anandamide), formed by phosphodiesterase-mediated cleav-
age of N-arachidonoyl-phosphatidylethanolamine [1,2], binds
to speci¢c CB1 and CB2 cannabinoid receptors expressed pri-
marily in the nervous system and the periphery, respectively
[3^7]. Since anandamide also occurs in the human brain and
various peripheral tissues [8], and it can elicit typical canna-
bimimetic responses [9,10], it is generally considered to be an
endogenous cannabinoid. For this reason, it is of great inter-
est to identify the signal transduction mechanisms which are
regulated by anandamide. Previous studies identi¢ed the ad-
enylyl cyclase system [11^14], calcium channels [15,16], the
intercellular calcium signalling system [17] and mitogen-acti-
vated protein kinases [18] as targets of anandamide actions.
Phospholipase D (PLD)-mediated hydrolysis of phospha-
tidylcholine (PtdCho) and phosphatidylethanolamine (PtdEtn)
produces phosphatidic acid [19,20], which has the potential to
act both as a mitogen (reviewed in [19]) and a regulator of
intracellular (Golgi) protein tra⁄cking [21,22]. Phosphatidic
acid can also be degraded to 1,2-diacylglycerol, an important
endogenous activator of the protein kinase C system, which in
turn plays a role in the cell growth regulation [23]. Because
PLD can in£uence a variety of di¡erent cellular processes,
including the formation of anandamide itself, we tested the
possible e¡ects of anandamide on PLD-mediated PtdCho and
PtdEtn hydrolysis in the rat pheochromocytoma PC12 cells
and NIH 3T3 cells. PC12 cells were chosen because they are
widely used models to study the neuronal di¡erentiation, they
also produce anandamide [24] and express a well-character-
ized PLD system which responds to nerve growth factor
(NGF) and phorbol 12-myristate 13-acetate (PMA) [25^27].
On the other hand, while NIH 3T3 ¢broblasts also express the
PtdCho- and PtdEtn-hydrolyzing PLD systems [28^30], they
are not known to produce anandamide or express cannabi-
noid receptors.
So far, very few observations have been reported dealing
with the possible regulation of PLD by cannabinoids. Thus, in
an earlier report [5], anandamide was found to stimulate the
arachidonic acid release but not the PLD activity in Chinese
hamster ovary cells expressing the human brain-speci¢c can-
nabinoid receptor. However, in mouse peritoneal cells, v9-tet-
rahydrocannabinol stimulated the PLD-mediated formation
of phosphatidylethanol (PtdEtOH) [31]. Here we show that
in PC12 cells, but not in NIH 3T3 cells, relatively low con-
centrations of anandamide can stimulate the PLD-mediated
hydrolysis of both PtdCho and PtdEtn.
2. Materials and methods
2.1. Materials
Anandamide and arachidonic acid were bought from Matreya.
PMA, N-oleoylethanolamide, arachidonic acid ethyl ester (AAEE)
and Dowex-50W (H form) were purchased from Sigma. NGF was
from Boehringer Mannheim, PtdEtOH was bought from Avanti Polar
Lipids. 2-[14C]ethanolamine (50 mCi/mmol), 1-[14C]palmitic acid (60
mCi/mmol) and mrthyl-[14C]choline chloride (50 mCi/mmol) were
purchased from Amersham. Tissue culture reagents, including fetal
calf serum, were from Gibco BRL.
2.2. Cell culture
PC12 cells (American Type Culture Collection) were maintained in
75 cm2 £asks as loosely attached cultures in RPMI 1640 medium
containing 10% heat-inactivated horse serum, 5% fetal calf serum,
50 U/ml of penicillin and 50 Wg/ml of streptomycin. Suspended cells
were harvested for the experiments after shaking the £asks. NIH 3T3
clone-7 ¢broblasts, kindly provided by Dr Douglas R. Lowy (Nation-
al Cancer Institute, NIH, Bethesda, MD, USA), were cultured in
Dulbecco’s modi¢ed Eagle’s medium supplemented with 10% calf se-
rum, penicillin-streptomycin (50 U/ml and 50 Wg/ml, respectively) and
glutamine (2 mM).
2.3. Measurement of PtdEtOH formation in PC12 cells
PC12 cells grown in £asks were incubated in complete medium for
48 h with 1-[14C]palmitic acid (0.5 WCi/ml). The cells were harvested,
washed and incubated in new £asks for another 2 h in fresh serum-
free medium to facilitate esteri¢cation of remaining free radiolabelled
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palmitic acid. Washed, suspended cells (V1.3^1.5U106 cells/ml) were
then incubated in serum-free medium (0.75 ml ¢nal volume) for 15 min
in the presence of 150 mM ethanol and PLD activators. Incubations
were stopped by adding 4 ml chloroform:methanol (1:1) to the tubes.
After phase separation, PtdEtOH was separated on potassium oxalate
(1%)-impregnated Silica Gel H plates as described earlier [32].
2.4. Determination of the PLD-mediated formation of [14C]choline and
[14C]ethanolamine
Loosely attached PC12 cells grown in £asks as well as attached
NIH 3T3 ¢broblasts grown in 12-well plates in full medium were
labelled with [14C]choline (0.75 WCi/ml) or [14C]ethanolamine
(0.5 WCi/ml) for 48 h. At the end of the labelling period, the density
of PC12 cells was around 1.3^1.5U106 cells/ml, while attached ¢bro-
blasts were V90% con£uent. Cells were washed and then incubated
for 3 h in fresh serum-free medium to complete the incorporation of
the remaining radioactive precursors into the corresponding cellular
phospholipids. Treatments of newly washed suspended PC12 and at-
tached NIH 3T3 cells were performed in serum-free medium (0.75 ml
¢nal volume) for 15 min. In case of PC12 cells, the incubations were
terminated as above, while NIH 3T3 cells were scraped into 2 ml ice-
cold methanol and rapidly transferred to tubes containing 2 ml
chloroform. After phase separation, radiolabelled choline and etha-
nolamine were separated from other products on Dowex 50W-H-
packed columns as described earlier [33].
3. Results
In [14C]choline- and [14C]ethanolamine-labelled cells, the
loss of the corresponding radiolabelled phospholipids upon
treatments with PMA, growth factors and numerous other
agents usually occurs by a PLD-mediated mechanism [19].
Thus, in the ¢rst experiments, PC12 cells prelabelled with
these precursors were used to examine the possible e¡ects of
anandamide phospholipid hydrolysis. In [14C]choline-labelled
PC12 cells, a detectable increase in the formation of
[14C]choline from [14C]PtdCho was elicited by 0.1 WM anan-
damide and a maximal (V2.5-fold) stimulatory e¡ect required
about 1 WM anandamide (Fig. 1). In [14C]ethanolamine-la-
belled PC12 cells, 1 WM anandamide also enhanced the for-
mation of [14C]ethanolamine from [14C]PtdEtn about 1.6-fold
(Fig. 1). However, the PtdEtn-hydrolyzing PLD system was
clearly less sensitive to anandamide compared to the PtdCho-
hydrolyzing PLD. In other experiments, a 15 min incubation
period was found to be optimal for the detection of these
anandamide e¡ects.
In prelabelled PC12 cells, a maximal e¡ective concentration
(100 nM) of PMA and 1 WM anandamide induced the hydrol-
ysis of both PtdCho and PtdEtn to similar extents (Fig. 2).
However, an optimal concentration (200 ng/ml) of NGF en-
hanced only PtdCho but not PtdEtn hydrolysis (Fig. 2). In-
terestingly, neither oleoylethanolamide nor arachidonic acid,
each examined at 1 WM concentration, stimulated the PtdCho
hydrolysis. In contrast, 1 WM AAEE was about 60^70% as
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Fig. 1. Stimulatory e¡ects of anandamide on the hydrolysis of
PtdCho and PtdEtn in PC12 cells. PC12 cells, prelabelled with ei-
ther [14C]choline (b) or [14C]ethanolamine (R) for 48 h, were
treated for 15 min with 0.1^10 WM concentrations of anandamide.
Newly formed radiolabelled choline and ethanolamine were analyzed
as described under Section 2. The average 14C content of PtdCho
and PtdEtn was 166 000 and 268 000 dpm/106 cells, respectively.
Each point represents the mean þ S.E.M. of three experiments each
performed in triplicate. *Signi¢cantly (P6 0.05^0.01) di¡erent from
the value obtained without anandamide (unpaired t-test).
Fig. 2. Comparison of the e¡ects of anandamide, PMA and NGF
on the hydrolysis of PtdCho and PtdEtn in PC12 cells. PC12 cells,
prelabelled with either [14C]choline or [14C]ethanolamine for 48 h,
were incubated for 15 min in the absence (E) or presence of 1 WM
anandamide (hatched), 200 ng/ml NGF (cross-hatched) or 100 nM
PMA (F). The data are the means þ S.E.M. of three experiments
each performed in triplicate. *Signi¢cantly (P6 0.01) di¡erent from
the corresponding value obtained in the absence of activators.
Fig. 3. Comparison of the e¡ects of anandamide, PMA and NGF
on the PtdEtOH formation in PC12 cells. [14C]palmitic acid-prela-
belled PC12 cells were incubated for 15 min in the presence of
150 mM ethanol in the absence (E) or presence of 1 WM anand-
amide (hatched), 100 nM PMA (cross-hatched) or 200 ng/ml NGF
(F). The average 14C content of total phospholipid was 306 000
dpm/106 cells. The data are the means þ S.D. of six incubations in a
single experiment. This experiment was repeated once (n = 4) with
similar results. *Signi¢cantly (P6 0.01) di¡erent from the value ob-
tained without activators.
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e¡ective as anandamide in stimulating both PtdCho and
PtdEtn hydrolysis (data not shown). It should be added that
in PC12 cells the basal rate of ethanolamine formation was
about three times greater than the formation of choline. While
this may re£ect a higher activity state of the PtdEtn-hydro-
lyzing PLD enzyme, this possibility remains to be determined.
PLD catalyzes the formation of phosphatidylalcohol in the
presence of a primary alcohol. Treatment of [14C]palmitic
acid-prelabelled PC12 cells with 1 WM anandamide in the
presence of 150 mM ethanol resulted in about a 3.6-fold in-
crease in [14C]PtdEtOH formation from prelabelled cellular
phospholipids (Fig. 3). PMA and NGF caused similar in-
creases in PtdEtOH formation (Fig. 3).
In NIH 3T3 ¢broblasts, numerous agents, including PMA,
stimulate PLD-mediated hydrolysis of both PtdCho and
PtdEtn [19,28^30]. However, in [14C]choline-labelled NIH
3T3 cells, 1^10 WM concentrations of anandamide were un-
able to stimulate [14C]PtdCho hydrolysis or to enhance the
e¡ect of PMA (Fig. 4A). Similarly, in [14C]ethanolamine-la-
belled NIH 3T3 cells, anandamide alone had no e¡ect on the
hydrolysis of [14C]PtdEtn (Fig. 4B). Interestingly, in these
cells, 10 WM anandamide slightly (1.3-fold), but signi¢cantly,
enhanced the stimulatory e¡ect of PMA on the [14C]PtdEtn
hydrolysis (Fig. 4B). However, in other studies, several mem-
brane interacting agents, including sphingosine ([29]), ethanol
([34]) and tamoxifen (Z. Kiss, unpublished observation), also
enhanced the e¡ect of PMA on the PtdEtn hydrolysis. Thus,
the potentiating e¡ect of 10 WM anandamide on PMA-in-
duced PtdEtn hydrolysis probably occurs by a non-speci¢c
mechanism.
4. Discussion
The major ¢nding of this work is that in PC12 cells rela-
tively low concentrations of anandamide were able to stimu-
late the PLD-mediated hydrolysis of both PtdCho and
PtdEtn. The e¡ects of anandamide were not mimicked by
oleoylethanolamide or arachidonic acid each used at a rele-
vant (1 WM) concentration. In contrast to PC12 cells, in NIH
3T3 ¢broblasts, anandamide did not stimulate the hydrolysis
of either of these phospholipids, although the PLD system in
these cells responds to many widely di¡erent agents, including
PMA, growth factors, oxidants, sphingosine and tamoxifen
(reviewed in [19]). Overall, these observations suggest that
the e¡ects of anandamide on PLD activation are mediated
by a speci¢c mechanism(s) not generally present in all cell
types.
On the other hand, receptor-mediated e¡ects of ananda-
mide on pre-implantation mouse embryo were observed in
the 3.5^14 nM concentration range [35] and 0.1^1 WM con-
centrations of anandamide were able to enhance the growth of
myeloblastic cells by a receptor-independent mechanism [36].
An additional interesting ¢nding (reported here) is that
AAEE, which is not known to interact with either the CB1
or CB2 receptor, partially mimicked the e¡ects of anandamide
on the PLD activity in PC12 cells. Finally, and perhaps most
importantly, in a Chinese hamster ovary cell line highly ex-
pressing the brain-speci¢c cannabinoid receptor, anandamide
had no e¡ects on the PLD activity [5]. When taken together,
these observations do not seem to support the mediatory role
of the presently known cannabinoid receptors. However, it
should be added that other receptors may exist for anand-
amide [37] and that the non-receptor-mediated e¡ects of
anandamide may be as important as the receptor-mediated
ones [17].
Clearly, further work is required to determine the mecha-
nism of anandamide e¡ects on the phospholipid hydrolysis
including the involvement of cannabinoid receptors. However,
regardless of the mechanism involved, an even more impor-
tant question concerns the possible physiological relevance of
anandamide e¡ects on the PLD activity. In this context, the
¢rst important consideration is that the e¡ects of anandamide
on the PLD activity required concentrations which may be in
the physiological range [8]. Furthermore, since the PtdCho-
and PtdEtn-hydrolyzing PLD activities can be activated by
many diverse stimuli [19,20], it is conceivable that the activity
of the anandamide-synthesizing PLD can also be upregulated
by certain physiological factors. Second, PLD is a potentially
important regulator of intracellular vesicle-mediated protein
tra⁄cking and cell growth [38^42]. Therefore, PLD activation
may play a role in the mediation of positive anandamide
e¡ects on various growth regulatory signal transduction
events such as the activation of mitogen-activated protein
kinase [18]. Third, although only two cell lines were analyzed
here, the results suggest that anandamide may target PLD
activities only in certain tissues. If so, this would provide an
additional level of speci¢city of these anandamide e¡ects.
In summary, here we have reported the novel ¢nding that
relatively low concentrations of anandamide stimulate the
PLD activity in PC12 but not in NIH 3T3 cells. Although
both the mechanism and the physiological signi¢cance of
these e¡ects remain to be determined, it is likely that stimu-
lation of PLD activity contributes to the physiological actions
of anandamide.
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Fig. 4. Anandamide does not stimulate the PLD activity in NIH
3T3 ¢broblasts. NIH 3T3 ¢broblasts, prelabelled with [14C]choline
(A) or [14C]ethanolamine (B) for 48 h, were untreated or treated
with 100 nM PMA for 15 min, as indicated, in the absence (E) or
presence of 1 WM anandamide (cross-hatched) or 10 WM ananda-
mide (F). The data are the means þ S.D. of six incubations in a sin-
gle experiment. Similar results were obtained in another experiment
(n = 3). *Signi¢cantly (P6 0.01) di¡erent from the value obtained
with PMA alone.
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